Cargando…

Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements

PURPOSE: The use of veterinary low tetrahydrocannabinol (THC) Cannabis sativa (ie, hemp) products has increased in popularity for a variety of pet ailments. Low-THC Cannabis sativa is federally legal for sale and distribution in the USA, and the rise in internet commerce has provided access to inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakshlag, Joseph J, Cital, Stephen, Eaton, Scott J, Prussin, Reece, Hudalla, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169471/
https://www.ncbi.nlm.nih.gov/pubmed/32346530
http://dx.doi.org/10.2147/VMRR.S248712
_version_ 1783523795427917824
author Wakshlag, Joseph J
Cital, Stephen
Eaton, Scott J
Prussin, Reece
Hudalla, Christopher
author_facet Wakshlag, Joseph J
Cital, Stephen
Eaton, Scott J
Prussin, Reece
Hudalla, Christopher
author_sort Wakshlag, Joseph J
collection PubMed
description PURPOSE: The use of veterinary low tetrahydrocannabinol (THC) Cannabis sativa (ie, hemp) products has increased in popularity for a variety of pet ailments. Low-THC Cannabis sativa is federally legal for sale and distribution in the USA, and the rise in internet commerce has provided access to interested consumers, with minimal quality control. MATERIALS AND METHODS: We performed an internet word search of “hemp extract and dog” or “CBD product and dog” and analyzed 29 products that were using low-THC Cannabis sativa extracts in their production of supplements. All products were tested for major cannabinoids including cannabidiol (CBD), ∆9-tetrahydrocannabinol (THC), cannabigerol (CBG), and other minor cannabinoids, as well as their carboxylic acid derivatives (CBDA, THCA, CBGA) using an ISO/IEC 17025 certified laboratory. Products were also tested for major terpenes and heavy metals to understand constituents in the hemp plants being extracted and distributed. RESULTS: All products were below the federal limit of 0.3% THC with variable amounts of CBD (0–88 mg/mL or g). Only two products did not supply a CBD or total cannabinoid concentration on their packaging or website, while 22/29 could supply a certificate of analysis (COA) from a third-party laboratory. Ten of the 27 products were within 10% of the total cannabinoid concentrations of their label claim with a median concentration of 93% of claims (0–154%). Heavy metal contamination was found in 4/29 products, with lead being the most prevalent contaminant (3/29). CONCLUSION: The products analyzed had highly variable concentrations of CBD or total cannabinoids with only 18 of 29 being appropriately labeled according to current FDA non-medication, non-dietary supplement or non-food guidelines. Owners and veterinarians wanting to utilize CBD-rich Cannabis sativa products should be aware of low-concentration products and should obtain a COA enabling them to fully discuss the implications of use and calculated dosing before administering to pets.
format Online
Article
Text
id pubmed-7169471
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-71694712020-04-28 Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements Wakshlag, Joseph J Cital, Stephen Eaton, Scott J Prussin, Reece Hudalla, Christopher Vet Med (Auckl) Original Research PURPOSE: The use of veterinary low tetrahydrocannabinol (THC) Cannabis sativa (ie, hemp) products has increased in popularity for a variety of pet ailments. Low-THC Cannabis sativa is federally legal for sale and distribution in the USA, and the rise in internet commerce has provided access to interested consumers, with minimal quality control. MATERIALS AND METHODS: We performed an internet word search of “hemp extract and dog” or “CBD product and dog” and analyzed 29 products that were using low-THC Cannabis sativa extracts in their production of supplements. All products were tested for major cannabinoids including cannabidiol (CBD), ∆9-tetrahydrocannabinol (THC), cannabigerol (CBG), and other minor cannabinoids, as well as their carboxylic acid derivatives (CBDA, THCA, CBGA) using an ISO/IEC 17025 certified laboratory. Products were also tested for major terpenes and heavy metals to understand constituents in the hemp plants being extracted and distributed. RESULTS: All products were below the federal limit of 0.3% THC with variable amounts of CBD (0–88 mg/mL or g). Only two products did not supply a CBD or total cannabinoid concentration on their packaging or website, while 22/29 could supply a certificate of analysis (COA) from a third-party laboratory. Ten of the 27 products were within 10% of the total cannabinoid concentrations of their label claim with a median concentration of 93% of claims (0–154%). Heavy metal contamination was found in 4/29 products, with lead being the most prevalent contaminant (3/29). CONCLUSION: The products analyzed had highly variable concentrations of CBD or total cannabinoids with only 18 of 29 being appropriately labeled according to current FDA non-medication, non-dietary supplement or non-food guidelines. Owners and veterinarians wanting to utilize CBD-rich Cannabis sativa products should be aware of low-concentration products and should obtain a COA enabling them to fully discuss the implications of use and calculated dosing before administering to pets. Dove 2020-04-15 /pmc/articles/PMC7169471/ /pubmed/32346530 http://dx.doi.org/10.2147/VMRR.S248712 Text en © 2020 Wakshlag et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wakshlag, Joseph J
Cital, Stephen
Eaton, Scott J
Prussin, Reece
Hudalla, Christopher
Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements
title Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements
title_full Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements
title_fullStr Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements
title_full_unstemmed Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements
title_short Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements
title_sort cannabinoid, terpene, and heavy metal analysis of 29 over-the-counter commercial veterinary hemp supplements
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169471/
https://www.ncbi.nlm.nih.gov/pubmed/32346530
http://dx.doi.org/10.2147/VMRR.S248712
work_keys_str_mv AT wakshlagjosephj cannabinoidterpeneandheavymetalanalysisof29overthecountercommercialveterinaryhempsupplements
AT citalstephen cannabinoidterpeneandheavymetalanalysisof29overthecountercommercialveterinaryhempsupplements
AT eatonscottj cannabinoidterpeneandheavymetalanalysisof29overthecountercommercialveterinaryhempsupplements
AT prussinreece cannabinoidterpeneandheavymetalanalysisof29overthecountercommercialveterinaryhempsupplements
AT hudallachristopher cannabinoidterpeneandheavymetalanalysisof29overthecountercommercialveterinaryhempsupplements